SKI Market

A+| A| A-|

Indian Indices

Sensex

75,508.54 899.56
( 1.21%)

Global Indices

Nasdaq

49,714.12 -67.45
(-0.14%)

Dow Jones

7,466.35 44.39
(0.60%)

Hang Seng

62,791.91 -480.20
(-0.76%)

Nikkei 225

10,300.99 35.67
(0.35%)

Forex

USD-INR

95.60 0.47
(0.49%)

EUR-INR

112.29 0.30
(0.26%)

GBP-INR

129.50 0.02
(0.02%)

JPY-INR

0.61 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

375.7898972

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

32.79

105592.45

EPS(TTM)

Face Value()

Div & Yield %

38.58

0.63

Back

global education ltd

Minda Corporation consolidated net profit rises 32.25% in the December 2025 quarter

Feb 05,2026

Net profit of Minda Corporation rose 32.25% to Rs 85.70 crore in the quarter ended December 2025 as against Rs 64.80 crore during the previous quarter ended December 2024. Sales rose 24.57% to Rs 1560.29 crore in the quarter ended December 2025 as against Rs 1252.56 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1560.29	1252.56	25
OPM %	11.76	11.46	-
PBDT	158.33	140.75	12
PBT	100.62	90.39	11
NP	85.70	64.80	32

75,508.54 899.56 ( 1.21%)

49,714.12 -67.45 (-0.14%)

7,466.35 44.39 (0.60%)

62,791.91 -480.20 (-0.76%)

10,300.99 35.67 (0.35%)

95.60 0.47 (0.49%)

112.29 0.30 (0.26%)

129.50 0.02 (0.02%)

0.61 0.00 (0.19%)